Dr Ryan P Kunkel, MD | |
5203 Juan Tabo Blvd Ne Ste 1c, Albuquerque, NM 87111-2683 | |
(505) 299-4900 | |
Not Available |
Full Name | Dr Ryan P Kunkel |
---|---|
Gender | Male |
Speciality | Plastic And Reconstructive Surgery |
Experience | 10 Years |
Location | 5203 Juan Tabo Blvd Ne Ste 1c, Albuquerque, New Mexico |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1144648627 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208200000X | Plastic Surgery | 11784145-1205 (Utah) | Secondary |
208200000X | Plastic Surgery | NM2021-0692 (New Mexico) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Presbyterian Hospital | Albuquerque, NM | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Presbyterian Healthcare Services | 9234041708 | 1099 |
News Archive
NephroGenex, Inc., a privately held drug development company focusing on kidney disease, today announced the completion of patient enrollment in its Phase 2b clinical trial (PYR-210) studying the safety and efficacy of its lead drug candidate Pyridorin (pyridoxamine dihydrochloride) in type 2 diabetic patients with overt diabetic nephropathy. Three hundred and seventeen (317) patients have been randomized.
Researchers at Signature Genomic Laboratories, which performs diagnostic genetic testing of chromosome abnormalities in individuals with unexplained physical and developmental disabilities, recently showed that microarray analysis can identify small DNA alterations in individuals with Pitt-Hopkins syndrome, a rare and poorly characterized genetic disorder.
The majority of hospitals participating in the American College of Surgeons National Surgical Quality Improvement Project improve surgical outcomes over time, and improvement continues with each year that hospitals participate in the program, according to a new study published online today in Annals of Surgery.
After being laid off from her job as a systems analyst for a specialty chemicals company in December, Gabriela de Pompignan opted to hang on to her former employer's insurance coverage under the federal law known as COBRA.
› Verified 9 days ago
Entity Name | Presbyterian Healthcare Services |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1104802354 PECOS PAC ID: 9234041708 Enrollment ID: O20031103000603 |
News Archive
NephroGenex, Inc., a privately held drug development company focusing on kidney disease, today announced the completion of patient enrollment in its Phase 2b clinical trial (PYR-210) studying the safety and efficacy of its lead drug candidate Pyridorin (pyridoxamine dihydrochloride) in type 2 diabetic patients with overt diabetic nephropathy. Three hundred and seventeen (317) patients have been randomized.
Researchers at Signature Genomic Laboratories, which performs diagnostic genetic testing of chromosome abnormalities in individuals with unexplained physical and developmental disabilities, recently showed that microarray analysis can identify small DNA alterations in individuals with Pitt-Hopkins syndrome, a rare and poorly characterized genetic disorder.
The majority of hospitals participating in the American College of Surgeons National Surgical Quality Improvement Project improve surgical outcomes over time, and improvement continues with each year that hospitals participate in the program, according to a new study published online today in Annals of Surgery.
After being laid off from her job as a systems analyst for a specialty chemicals company in December, Gabriela de Pompignan opted to hang on to her former employer's insurance coverage under the federal law known as COBRA.
› Verified 9 days ago
Entity Name | Kunkel Plastic Surgery Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1467120592 PECOS PAC ID: 8325445083 Enrollment ID: O20210922001840 |
News Archive
NephroGenex, Inc., a privately held drug development company focusing on kidney disease, today announced the completion of patient enrollment in its Phase 2b clinical trial (PYR-210) studying the safety and efficacy of its lead drug candidate Pyridorin (pyridoxamine dihydrochloride) in type 2 diabetic patients with overt diabetic nephropathy. Three hundred and seventeen (317) patients have been randomized.
Researchers at Signature Genomic Laboratories, which performs diagnostic genetic testing of chromosome abnormalities in individuals with unexplained physical and developmental disabilities, recently showed that microarray analysis can identify small DNA alterations in individuals with Pitt-Hopkins syndrome, a rare and poorly characterized genetic disorder.
The majority of hospitals participating in the American College of Surgeons National Surgical Quality Improvement Project improve surgical outcomes over time, and improvement continues with each year that hospitals participate in the program, according to a new study published online today in Annals of Surgery.
After being laid off from her job as a systems analyst for a specialty chemicals company in December, Gabriela de Pompignan opted to hang on to her former employer's insurance coverage under the federal law known as COBRA.
› Verified 9 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Ryan P Kunkel, MD 5203 Juan Tabo Blvd Ne Ste 1c, Albuquerque, NM 87111-2683 Ph: () - | Dr Ryan P Kunkel, MD 5203 Juan Tabo Blvd Ne Ste 1c, Albuquerque, NM 87111-2683 Ph: (505) 299-4900 |
News Archive
NephroGenex, Inc., a privately held drug development company focusing on kidney disease, today announced the completion of patient enrollment in its Phase 2b clinical trial (PYR-210) studying the safety and efficacy of its lead drug candidate Pyridorin (pyridoxamine dihydrochloride) in type 2 diabetic patients with overt diabetic nephropathy. Three hundred and seventeen (317) patients have been randomized.
Researchers at Signature Genomic Laboratories, which performs diagnostic genetic testing of chromosome abnormalities in individuals with unexplained physical and developmental disabilities, recently showed that microarray analysis can identify small DNA alterations in individuals with Pitt-Hopkins syndrome, a rare and poorly characterized genetic disorder.
The majority of hospitals participating in the American College of Surgeons National Surgical Quality Improvement Project improve surgical outcomes over time, and improvement continues with each year that hospitals participate in the program, according to a new study published online today in Annals of Surgery.
After being laid off from her job as a systems analyst for a specialty chemicals company in December, Gabriela de Pompignan opted to hang on to her former employer's insurance coverage under the federal law known as COBRA.
› Verified 9 days ago
Richard Charles Gobeille, M. D. Plastic Surgery Medicare: Not Enrolled in Medicare Practice Location: 2601 Wyoming Blvd Ne, Suite 205, Albuquerque, NM 87112 Phone: 505-856-1619 | |
Neil T Chen, MD Plastic Surgery Medicare: Not Enrolled in Medicare Practice Location: 3830 Masthead Street Ne, Albuquerque, NM 87109 Phone: 505-842-8889 Fax: 505-842-8886 | |
Christopher P Demas, MD Plastic Surgery Medicare: Medicare Enrolled Practice Location: 2211 Lomas Blvd Ne, Albuquerque, NM 87106 Phone: 505-272-4264 Fax: 505-272-1669 | |
Cesar Luis Cuadros, M.D. Plastic Surgery Medicare: Not Enrolled in Medicare Practice Location: 8232 Louisiana Blvd Ne Ste A, Albuquerque, NM 87113 Phone: 505-243-7670 Fax: 505-242-0510 | |
Jon Dagley Wagner, MD DDS Plastic Surgery Medicare: Not Enrolled in Medicare Practice Location: 10000 Coors Byp Nw, Suite G-218, Albuquerque, NM 87114 Phone: 505-242-4867 | |
Anil Shetty, Plastic Surgery Medicare: Accepting Medicare Assignments Practice Location: 2211 Lomas Blvd Ne, University Of New Mexico Health Sciences Center, Albuquerque, NM 87106 Phone: 505-272-5504 Fax: 505-272-1669 |